Peer Review History
| Original SubmissionJanuary 27, 2026 |
|---|
|
Dear Dr. Montenegro Mendoza, Please submit your revised manuscript by Jun 21 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Guoying Wang, MD, PhD Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following financial disclosure: [The ENSPA study was funded by the Ministry of Health of Panama via Inter-American Development Bank. HQ and IMV are affiliated with the National Research System (“SNI” in Spanish).]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: [The author thanks all the ENSPA-2019 participants, as well as the staff who participated in the data collection process. HQ and IMV are affiliated with the National Research System (“SNI” in Spanish), which is funded by the National Secretary of Science and Technology (“SENACYT” in Spanish).] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [The ENSPA study was funded by the Ministry of Health of Panama via Inter-American Development Bank. HQ and IMV are affiliated with the National Research System (“SNI” in Spanish).]. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: The topic is extremely important. With increasing burden of non communicable diseases , research focusing on the risk factors is the need of hour. The pandemic of obesity is alarming and being obese does not ensure that the individual has no nutritional deficiencies which is supported by evidence in this article. The article is well written Reviewer #2: This manuscript examines the double burden of malnutrition among non-pregnant women of reproductive age in Panama using nationally representative data. The topic is very relevant to current public health concerns, and I appreciate the use of a large dataset and appropriate statistical approach. Overall, the manuscript is well organized, and the findings are clearly presented and generally supported by the data. However, the final analytical sample is smaller than the original survey sample due to exclusions. A short discussion on possible selection bias and whether the final sample remains representative would be useful. Overall, I found this to be a solid and relevant study that adds to the literature on the double burden of malnutrition. With a few clarifications and minor revisions, it would be suitable for publication. Reviewer #3: The introduction provides a strong rationale for the study and clearly highlights the public health importance of the double burden of malnutrition. However, the tone at times leans toward a normative or prescriptive perspective. I suggest reframing these sections to use a more analytical and descriptive tone, focusing on the epidemiological transitions and drivers rather than on societal deficits. For example, on page 1, the manuscript states: “Malnutrition in all its forms impacts the Human Capital Index and, therefore, the sustainable growth and poverty reductions of nations.” While this is a valid point of view, it is a normative framing of the problem. To shift toward a more positive or analytical academic style, this could be reframed to focus on the measurable relationship between health variables, such as: “The co-occurrence of different forms of malnutrition represents a challenge for human capital development, as the physiological impacts of both anemia and obesity have been shown to correlate with economic and productivity indicators at the national level.” Adopting this descriptive approach throughout the introduction will align the background more closely with the objective, data-driven nature of the results and the rigorous multinomial analysis you have performed. The authors state that the laboratory subsample (n = 5,212) was designed to be nationally representative and representative by area of residence. However, given the logistical requirements for biosample collection there is a potential risk of selection bias or non-participation bias compared to the full ENSPA-2019 survey sample (n = 17,997). To strengthen the validity of the findings regarding the double burden of malnutrition, it would be beneficial for the authors to include a comparative analysis of the sociodemographic characteristics (e.g., age, education level, wealth quintile, and geographic region) between the full survey sample and the laboratory subsample of NpWRA. Specifically: Table Comparison: Could the authors provide a table (as an appendix or within the results) comparing these key characteristics to demonstrate that no significant systematic differences exist? Bias Discussion: If differences are found, please discuss how these might impact the prevalence estimates and how the complex sampling weights used in the analysis account for this potential bias. This comparison would provide greater confidence that the subsample effectively preserves the representativeness of the original survey. If found that there is an important difference in distribution weights might need to be recalcualted. The data collection section is very comprehensive and provides a clear understanding of the study's execution. However, as the authors note that this methodology has been described in detail elsewhere (e.g., in the primary ENSPA-2019 report or previous publications), the current description in the manuscript is quite lengthy. To improve the flow and readability of the publication, I suggest the following: Summarize the Core Methods: Keep only the essential information necessary for the reader to understand the current analysis (e.g., the specific variables used for the double burden of malnutrition and the laboratory subsample flow). Move Detailed Protocols to an Annex: Transfer the more granular procedural details—such as specific equipment brands, detailed field staff training protocols, and step-by-step biosample handling—to a Supplementary Materials or Annex section. Cross-Reference: Ensure that the text clearly cites the original methodological publication or the new Annex for readers who require the full technical details. This adjustment would allow for a more concise manuscript that focuses more directly on the study’s specific findings regarding non-pregnant women of reproductive age. The Discussion section (pages 31–40) provides a thorough comparison of the study’s findings with similar data from other countries. However, much of the current text is dedicated to repeating the results and noting that they are "consistent with" or "similar to" findings in other regions. To increase the impact of the paper, I suggest the authors reduce the repetitive description of results and instead focus on the underlying reasons for these similarities or differences. Specifically, the manuscript would benefit from a deeper analysis of the "Panamanian paradox." For example: Economic Classification vs. Health Outcomes: Panama is classified as a High-Income Country (HIC), yet your results for the double burden of malnutrition and anemia are strikingly similar to those found in Low-Income Countries (LIC) or lower-middle-income regions. Drivers of Disparity: Rather than just stating that the results match other countries, please expand on why this occurs in Panama. Is it due to the specific nature of the country's high income inequality (as mentioned with the Gini index), the rapid pace of the nutrition transition, or specific gaps in the food system that transcend national wealth? Shifting the focus from what is happening in other countries to why Panama mirrors certain socioeconomic contexts despite its HIC status would provide a much more robust and insightful discussion. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Saadia Asiedu Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Double burden of malnutrition among non-pregnant women of reproductive age: results from the National Health Survey of Panama (ENSPA) 2019. PONE-D-26-04070R1 Dear Dr. Montenegro Mendoza, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Guoying Wang, MD, PhD Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The authors have addressed all points in previous review. It addresses a very important topic and is well written and analyzed .It is fit for publication Reviewer #2: Thank you for the opportunity to review the revised manuscript. I appreciate the authors' careful responses to the reviewers' comments and the revisions made throughout the manuscript. The authors have addressed the majority of my previous concerns. In particular, the additional clarification of the methodology, discussion of missing data, and improvements to the data availability statement have strengthened the manuscript. The revisions have improved the clarity and transparency of the study. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-26-04070R1 PLOS One Dear Dr. Mendoza, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS One and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Guoying Wang Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .